Menu
Back to User profile » Professor Kazuhiko Nakagawa
Papers published by Professor Kazuhiko Nakagawa:
Rationale and Design for a Multicenter, Phase II Study of Durvalumab Plus Concurrent Radiation Therapy in Locally Advanced Non-Small Cell Lung Cancer: The DOLPHIN Study (WJOG11619L)
Tachihara M, Tsujino K, Ishihara T, Hayashi H, Sato Y, Kurata T, Sugawara S, Okamoto I, Teraoka S, Azuma K, Daga H, Yamaguchi M, Kodaira T, Satouchi M, Shimokawa M, Yamamoto N, Nakagawa K
Cancer Management and Research 2021, 13:9167-9173
Published Date: 14 December 2021
Successful long-term treatment of non–small cell lung cancer positive for RET rearrangement with pemetrexed
Takeda M, Sakai K, Nishio K, Nakagawa K
OncoTargets and Therapy 2019, 12:5355-5358
Published Date: 8 July 2019
Clinical development of nintedanib for advanced non-small-cell lung cancer
Takeda M, Okamoto I, Nakagawa K
Therapeutics and Clinical Risk Management 2015, 11:1701-1706
Published Date: 16 November 2015
Clinical utility of erlotinib for the treatment of non-small-cell lung cancer in Japanese patients: current evidence
Togashi Y, Hayashi H, Nakagawa K, Nishio K
Drug Design, Development and Therapy 2014, 8:1037-1046
Published Date: 31 July 2014
Nimotuzumab, a novel monoclonal antibody to the epidermal growth factor receptor, in the treatment of non-small cell lung cancer
Takeda M, Okamoto I, Nishimura Y, Nakagawa K
Lung Cancer: Targets and Therapy 2011, 2:59-67
Published Date: 14 October 2011